{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:28:37Z","timestamp":1787052517309,"version":"build-2736575974"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01896-5","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:10:35Z","timestamp":1787004635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oxyberberine-nanoparticle attenuates the cognitive deficits in a transgenic mouse model of Alzheimer\u2019s disease via modulating gut microbiota through suppressing CXCL10\/CXCR3 pathway"],"prefix":"10.1038","author":[{"given":"Yu-lin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-hui","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-yao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-yang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-xiu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-fang","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"1896_CR1","doi-asserted-by":"crossref","unstructured":"Maji M, Khajanchi S. Mathematical models on Alzheimer\u2019s disease and its treatment: A review. Phys Life Rev. 2025;52:207\u201344.","DOI":"10.1016\/j.plrev.2025.01.004"},{"key":"1896_CR2","doi-asserted-by":"crossref","unstructured":"Wang R. Global burden of Alzheimer\u2019s disease and other dementias during 1990-2021: A global burden of disease and risk factors study 2021-based study. Neuroepidemiology. 2026;60:16\u201327.","DOI":"10.1159\/000543578"},{"key":"1896_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/brain\/awae325","volume":"148","author":"GG Kovacs","year":"2025","unstructured":"Kovacs GG, Katsumata Y, Wu X, Aung KZ, Fardo DW, Forrest SL, et al. Amyloid-\u03b2 predominant Alzheimer\u2019s disease neuropathologic change. Brain. 2025;148:401\u20137.","journal-title":"Brain"},{"key":"1896_CR4","doi-asserted-by":"crossref","unstructured":"Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L. Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther. 2024;9:211.","DOI":"10.1038\/s41392-024-01911-3"},{"key":"1896_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.31083\/j.jin2311197","volume":"23","author":"F Zhou","year":"2024","unstructured":"Zhou F, Zhao Y, Sun Y, Chen W. Molecular insights into Tau pathology and its therapeutic strategies in Alzheimer\u2019s disease. J Integr Neurosci. 2024;23:197.","journal-title":"J Integr Neurosci"},{"key":"1896_CR6","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.2147\/CIA.S159920","volume":"13","author":"N Zhang","year":"2018","unstructured":"Zhang N, Gordon ML. Clinical efficacy and safety of donepezil in the treatment of Alzheimer\u2019s disease in Chinese patients. Clin Interv Aging. 2018;13:1963\u201370.","journal-title":"Clin Interv Aging"},{"key":"1896_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1831","volume":"10","author":"J Guo","year":"2020","unstructured":"Guo J, Wang Z, Liu R, Huang Y, Zhang N, Zhang R. Memantine, donepezil, or combination therapy-what is the best therapy for Alzheimer\u2019s disease? A network meta-analysis. Brain Behav. 2020;10:e01831.","journal-title":"Brain Behav"},{"key":"1896_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40035-022-00292-3","volume":"11","author":"C Song","year":"2022","unstructured":"Song C, Shi J, Zhang P, Zhang Y, Xu J, Zhao L, et al. Immunotherapy for Alzheimer\u2019s disease: targeting \u03b2-amyloid and beyond. Transl Neurodegener. 2022;11:18.","journal-title":"Transl Neurodegener"},{"key":"1896_CR9","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1248\/cpb.c24-00069","volume":"72","author":"N Suzuki","year":"2024","unstructured":"Suzuki N, Hatta T, Ito M, Kusakabe KI. Anti-amyloid-\u03b2 antibodies and anti-tau therapies for Alzheimer\u2019s disease: Recent advances and perspectives. Chem Pharm Bull. 2024;72:602\u20139.","journal-title":"Chem Pharm Bull"},{"key":"1896_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.952332","volume":"13","author":"Z Shi","year":"2022","unstructured":"Shi Z, Chen H, Zhou X, Yang W, Lin Y. Pharmacological effects of natural medicine ginsenosides against Alzheimer\u2019s disease. Front Pharmacol. 2022;13:952332.","journal-title":"Front Pharmacol"},{"key":"1896_CR11","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s13311-019-00767-8","volume":"16","author":"SK Singh","year":"2019","unstructured":"Singh SK, Srivastav S, Castellani RJ, Plascencia-Villa G, Perry G. Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders. Neurotherapeutics. 2019;16:666\u201374.","journal-title":"Neurotherapeutics"},{"key":"1896_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1142\/S0192415X24500277","volume":"52","author":"Y Peng","year":"2024","unstructured":"Peng Y, Chen Q, Xue YH, Jin H, Liu S, Du MQ, et al. Ginkgo biloba and its chemical components in the management of Alzheimer\u2019s disease. Am J Chin Med. 2024;52:625\u201366.","journal-title":"Am J Chin Med"},{"key":"1896_CR13","doi-asserted-by":"publisher","first-page":"14835","DOI":"10.3390\/ijms232314835","volume":"23","author":"A Calderaro","year":"2022","unstructured":"Calderaro A, Patan\u00e8 GT, Tellone E, Barreca D, Ficarra S, Misiti F, et al. The Neuroprotective potentiality of flavonoids on Alzheimer\u2019s disease. Int J Mol Sci. 2022;23:14835.","journal-title":"Int J Mol Sci"},{"key":"1896_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11010-023-04922-w","volume":"480","author":"M Al Amin","year":"2025","unstructured":"Al Amin M, Dehbia Z, Nafady MH, Zehravi M, Kumar KP, Haque MA, et al. Flavonoids and Alzheimer\u2019s disease: reviewing the evidence for neuroprotective potential. Mol Cell Biochem. 2025;480:43\u201373.","journal-title":"Mol Cell Biochem"},{"key":"1896_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","volume":"17","author":"H Kadry","year":"2020","unstructured":"Kadry H, Noorani B, Cucullo L. A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020;17:69.","journal-title":"Fluids Barriers CNS"},{"key":"1896_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121690","volume":"288","author":"G Zhong","year":"2022","unstructured":"Zhong G, Long H, Zhou T, Liu Y, Zhao J, Han J, et al. Blood-brain barrier Permeable nanoparticles for Alzheimer\u2019s disease treatment by selective mitophagy of microglia. Biomaterials. 2022;288:121690.","journal-title":"Biomaterials"},{"key":"1896_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122749","volume":"312","author":"A Xie","year":"2025","unstructured":"Xie A, Cheng G, Wu J, Li Z, Yu G, Zhu X, et al. Highly BBB-permeable nanomedicine reverses neuroapoptosis and neuroinflammation to treat Alzheimer\u2019s disease. Biomaterials. 2025;312:122749.","journal-title":"Biomaterials"},{"key":"1896_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3233\/JAD-170639","volume":"61","author":"CD Pereira","year":"2018","unstructured":"Pereira CD, Martins F, Wiltfang J, da Cruz ESOAB, Rebelo S. ABC transporters are key players in Alzheimer\u2019s disease. J Alzheimers Dis. 2018;61:463\u201385.","journal-title":"J Alzheimers Dis"},{"key":"1896_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1083\/jcb.201709069","volume":"217","author":"DV Hansen","year":"2018","unstructured":"Hansen DV, Hanson JE, Sheng M. Microglia in Alzheimer\u2019s disease. J Cell Biol. 2018;217:459\u201372.","journal-title":"J Cell Biol"},{"key":"1896_CR20","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s12031-022-02047-1","volume":"72","author":"J Wojcieszak","year":"2022","unstructured":"Wojcieszak J, Kuczy\u0144ska K, Zawilska JB. Role of chemokines in the development and progression of Alzheimer\u2019s disease. J Mol Neurosci. 2022;72:1929\u201351.","journal-title":"J Mol Neurosci"},{"key":"1896_CR21","doi-asserted-by":"crossref","unstructured":"Jorfi M, Park J, Hall CK, Lin CJ, Chen M, von Maydell D, et al. Infiltrating CD8+T cells exacerbate Alzheimer\u2019s disease pathology in a 3D human neuroimmune axis model. Nat Neurosci. 2023;26:1489\u2013504.","DOI":"10.1038\/s41593-023-01415-3"},{"key":"1896_CR22","doi-asserted-by":"crossref","unstructured":"Zhou YQ, Liu DQ, Chen SP, Sun J, Zhou XR, Xing C, et al. The role of CXCR3 in neurological diseases. Curr Neuropharmacol. 2019;17:142\u201350.","DOI":"10.2174\/1570159X15666171109161140"},{"key":"1896_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1172\/JCI66771","volume":"125","author":"M Krauthausen","year":"2015","unstructured":"Krauthausen M, Kummer MP, Zimmermann J, Reyes-Irisarri E, Terwel D, Bulic B, et al. CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer\u2019s disease model. J Clin Invest. 2015;125:365\u201378.","journal-title":"J Clin Invest"},{"key":"1896_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154962","volume":"118","author":"X Li","year":"2023","unstructured":"Li X, Chen J, Feng W, Wang C, Chen M, Li Y, et al. Berberine ameliorates iron levels and ferroptosis in the brain of 3 \u00d7 Tg-AD mice. Phytomedicine. 2023;118:154962.","journal-title":"Phytomedicine"},{"key":"1896_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41392-020-00456-5","volume":"6","author":"Y Wang","year":"2021","unstructured":"Wang Y, Tong Q, Ma SR, Zhao ZX, Pan LB, Cong L, et al. Oral berberine improves brain dopa\/dopamine levels to ameliorate Parkinson\u2019s disease by regulating gut microbiota. Signal Transduct Target Ther. 2021;6:77.","journal-title":"Signal Transduct Target Ther"},{"key":"1896_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104603","volume":"152","author":"C Li","year":"2020","unstructured":"Li C, Ai G, Wang Y, Lu Q, Luo C, Tan L, et al. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-\u03baB pathway. Pharmacol Res. 2020;152:104603.","journal-title":"Pharmacol Res"},{"key":"1896_CR27","doi-asserted-by":"crossref","unstructured":"Wu F, Lu F, Dong H, Hu M, Xu L, Wang D. Oxyberberine inhibits hepatic gluconeogenesis via AMPK-mediated suppression of FoxO1 and CRTC2 signaling axes. Phytother Res. 2025;39:5434\u201349.","DOI":"10.1002\/ptr.8381"},{"key":"1896_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154899","volume":"116","author":"C Li","year":"2023","unstructured":"Li C, Liu M, Deng L, Luo D, Ma R, Lu Q. Oxyberberine ameliorates TNBS-induced colitis in rats through suppressing inflammation and oxidative stress via Keap1\/Nrf2\/NF-\u03baB signaling pathways. Phytomedicine. 2023;116:154899.","journal-title":"Phytomedicine"},{"key":"1896_CR29","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.2147\/IJN.S464994","volume":"19","author":"Z Huang","year":"2024","unstructured":"Huang Z, Zhang S, Qin Z, Ai G, Li M, Gong S, et al. Supersaturated drug delivery system of oxyberberine based on cyclodextrin nanoaggregates: Preparation, characterization, and in vivo application. Int J Nanomed. 2024;19:5297\u2013316.","journal-title":"Int J Nanomed"},{"key":"1896_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2022.113215","volume":"166","author":"G Ai","year":"2022","unstructured":"Ai G, Wu X, Dou Y, Huang R, Zhong L, Liu Y, et al. Oxyberberine, a novel HO-1 agonist, effectively ameliorates oxidative stress and inflammatory response in LPS\/D-GalN induced acute liver injury mice via coactivating erythrocyte metabolism and Nrf2 signaling pathway. Food Chem Toxicol. 2022;166:113215.","journal-title":"Food Chem Toxicol"},{"key":"1896_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02704-1","volume":"20","author":"QQ Xu","year":"2023","unstructured":"Xu QQ, Su ZR, Yang W, Zhong M, Xian YF, Lin ZX. Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer\u2019s disease via modulating neuropathology and gut microbiota through suppressing C\/EBP\u03b2\/AEP pathway. J Neuroinflammat. 2023;20:19.","journal-title":"J Neuroinflammat"},{"key":"1896_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4754195","volume":"2020","author":"W Yang","year":"2020","unstructured":"Yang W, Liu Y, Xu QQ, Xian YF, Lin ZX. Sulforaphene ameliorates neuroinflammation and hyperphosphorylated Tau protein via regulating the PI3K\/Akt\/GSK-3\u03b2 pathway in experimental models of Alzheimer\u2019s disease. Oxid Med Cell Longev. 2020;2020:4754195.","journal-title":"Oxid Med Cell Longev"},{"key":"1896_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13057-w","volume":"10","author":"U Chon","year":"2019","unstructured":"Chon U, Vanselow DJ, Cheng KC, Kim Y. Enhanced and unified anatomical labeling for a common mouse brain atlas. Nat Commun. 2019;10:5067.","journal-title":"Nat Commun"},{"key":"1896_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cis.2016.06.006","volume":"244","author":"M Manciu","year":"2017","unstructured":"Manciu M, Manciu FS, Ruckenstein E. On the surface tension and Zeta potential of electrolyte solutions. Adv Colloid Interface Sci. 2017;244:90\u20139.","journal-title":"Adv Colloid Interface Sci"},{"key":"1896_CR35","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1146\/annurev-physchem-032511-143748","volume":"63","author":"S Roke","year":"2012","unstructured":"Roke S, Gonella G. Nonlinear light scattering and spectroscopy of particles and droplets in liquids. Annu Rev Phys Chem. 2012;63:353\u201378.","journal-title":"Annu Rev Phys Chem"},{"key":"1896_CR36","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.addr.2006.09.009","volume":"58","author":"VP Torchilin","year":"2006","unstructured":"Torchilin VP. Multifunctional nanocarriers. Adv Drug Deliv Rev. 2006;58:1532\u201355.","journal-title":"Adv Drug Deliv Rev"},{"key":"1896_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/17425247.2023.2154075","volume":"20","author":"X Wang","year":"2023","unstructured":"Wang X, Anton H, Vandamme T, Anton N. Updated insight into the characterization of nano-emulsions. Expert Opin Drug Deliv. 2023;20:93\u2013114.","journal-title":"Expert Opin Drug Deliv"},{"key":"1896_CR38","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.drudis.2019.02.007","volume":"24","author":"S Chaturvedi","year":"2019","unstructured":"Chaturvedi S, Rashid M, Malik MY, Agarwal A, Singh SK, Gayen JR, et al. Neuropharmacokinetics: a bridging tool between CNS drug development and therapeutic outcome. Drug Discov Today. 2019;24:1166\u201375.","journal-title":"Drug Discov Today"},{"key":"1896_CR39","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s13318-015-0281-6","volume":"41","author":"W Jun-Jun","year":"2016","unstructured":"Jun-Jun W, Xiao-Lei M, Jing-Ya C, Yong C. The pharmacokinetics and tissue distribution of honokiol and its metabolites in rats. Eur J Drug Metab Pharmacokinet. 2016;41:587\u201394.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"1896_CR40","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.neubiorev.2020.02.012","volume":"112","author":"F Kosel","year":"2020","unstructured":"Kosel F, Pelley JMS, Franklin TB. Behavioural and psychological symptoms of dementia in mouse models of Alzheimer\u2019s disease-related pathology. Neurosci Biobehav Rev. 2020;112:634\u201347.","journal-title":"Neurosci Biobehav Rev"},{"key":"1896_CR41","doi-asserted-by":"crossref","unstructured":"Barber AJ, Del Genio CL, Swain AB, Pizzi EM, Watson SC, Tapiavala VN, et al. Age, sex and Alzheimer\u2019s disease: a longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer\u2019s patients. Alzheimers Res Ther. 2024;16:134.","DOI":"10.1186\/s13195-024-01492-x"},{"key":"1896_CR42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003;39:409\u201321.","journal-title":"Neuron"},{"key":"1896_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12873","volume":"18","author":"R Belfiore","year":"2019","unstructured":"Belfiore R, Rodin A, Ferreira E, Velazquez R, Branca C, Caccamo A, et al. Temporal and regional progression of Alzheimer\u2019s disease-like pathology in 3xTg-AD mice. Aging Cell. 2019;18:e12873.","journal-title":"Aging Cell"},{"key":"1896_CR44","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1056\/NEJMoa2310168","volume":"390","author":"J Jia","year":"2024","unstructured":"Jia J, Ning Y, Chen M, Wang S, Yang H, Li F, et al. Biomarker changes during 20 years preceding Alzheimer\u2019s disease. N Engl J Med. 2024;390:712\u201322.","journal-title":"N Engl J Med"},{"key":"1896_CR45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00401-022-02528-y","volume":"145","author":"S Moonen","year":"2023","unstructured":"Moonen S, Koper MJ, Van Schoor E, Schaeverbeke JM, Vandenberghe R, von Arnim CAF, et al. Pyroptosis in Alzheimer\u2019s disease: cell type-specific activation in microglia, astrocytes and neurons. Acta Neuropathol. 2023;145:175\u201395.","journal-title":"Acta Neuropathol"},{"key":"1896_CR46","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s10787-021-00889-6","volume":"29","author":"R Dhapola","year":"2021","unstructured":"Dhapola R, Hota SS, Sarma P, Bhattacharyya A, Medhi B, Reddy DH. Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer\u2019s disease. Inflammopharmacology. 2021;29:1669\u201381.","journal-title":"Inflammopharmacology"},{"key":"1896_CR47","doi-asserted-by":"publisher","first-page":"10572","DOI":"10.3390\/ijms231810572","volume":"23","author":"NF Al-Ghraiybah","year":"2022","unstructured":"Al-Ghraiybah NF, Wang J, Alkhalifa AE, Roberts AB, Raj R, Yang E, et al. Glial cell-mediated neuroinflammation in Alzheimer\u2019s disease. Int J Mol Sci. 2022;23:10572.","journal-title":"Int J Mol Sci"},{"key":"1896_CR48","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.3390\/ijms24076518","volume":"24","author":"B Twarowski","year":"2023","unstructured":"Twarowski B, Herbet M. Inflammatory Processes in Alzheimer\u2019s disease-pathomechanism, diagnosis and treatment: A review. Int J Mol Sci. 2023;24:6518.","journal-title":"Int J Mol Sci"},{"key":"1896_CR49","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neulet.2019.04.022","volume":"705","author":"NN Naseri","year":"2019","unstructured":"Naseri NN, Wang H, Guo J, Sharma M, Luo W. The complexity of tau in Alzheimer\u2019s disease. Neurosci Lett. 2019;705:183\u201394.","journal-title":"Neurosci Lett"},{"key":"1896_CR50","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2174\/1567205014666170417111859","volume":"15","author":"Y Gao","year":"2018","unstructured":"Gao Y, Tan L, Yu JT, Tan L. Tau in Alzheimer\u2019s disease: mechanisms and therapeutic strategies. Curr Alzheimer Res. 2018;15:283\u2013300.","journal-title":"Curr Alzheimer Res"},{"key":"1896_CR51","doi-asserted-by":"crossref","unstructured":"Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB, et al. Identification of preclinical Alzheimer\u2019s disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheimers Dement. 2015;11:600\u20137.e1.","DOI":"10.1016\/j.jalz.2014.06.008"},{"key":"1896_CR52","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s43587-024-00599-y","volume":"4","author":"G Salvad\u00f3","year":"2024","unstructured":"Salvad\u00f3 G, Horie K, Barth\u00e9lemy NR, Vogel JW, Pichet Binette A, Chen CD, et al. Disease staging of Alzheimer\u2019s disease using a CSF-based biomarker model. Nat Aging. 2024;4:694\u2013708.","journal-title":"Nat Aging"},{"key":"1896_CR53","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1097\/WNR.0000000000001518","volume":"31","author":"Y Yang","year":"2020","unstructured":"Yang Y, Hu S, Lin H, He J, Tang C. Electroacupuncture at GV24 and bilateral GB13 improves cognitive ability via influences the levels of A\u03b2, p-tau (s396) and p-tau (s404) in the hippocampus of Alzheimer\u2019s disease model rats. Neuroreport. 2020;31:1072\u201383.","journal-title":"Neuroreport"},{"key":"1896_CR54","doi-asserted-by":"crossref","unstructured":"Calsolaro V, Edison P. Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions. Alzheimers Dement. 2016;12:719\u201332.","DOI":"10.1016\/j.jalz.2016.02.010"},{"key":"1896_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.856376","volume":"13","author":"Y Cai","year":"2022","unstructured":"Cai Y, Liu J, Wang B, Sun M, Yang H. Microglia in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease and related therapeutic targets. Front Immunol. 2022;13:856376.","journal-title":"Front Immunol"},{"key":"1896_CR56","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus H, Heneka MT. Microglia in Alzheimer\u2019s disease. J Clin Invest. 2017;127:3240\u20139.","journal-title":"J Clin Invest"},{"key":"1896_CR57","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1002\/glia.23024","volume":"64","author":"J Tischer","year":"2016","unstructured":"Tischer J, Krueger M, Mueller W, Staszewski O, Prinz M, Streit WJ, et al. Inhomogeneous distribution of Iba-1 characterizes microglial pathology in Alzheimer\u2019s disease. Glia. 2016;64:1562\u201372.","journal-title":"Glia"},{"key":"1896_CR58","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-024-00740-w","volume":"19","author":"S Kim","year":"2024","unstructured":"Kim S, Chun H, Kim Y, Kim Y, Park U, Chu J, et al. Astrocytic autophagy plasticity modulates A\u03b2 clearance and cognitive function in Alzheimer\u2019s disease. Mol Neurodegener. 2024;19:55.","journal-title":"Mol Neurodegener"},{"key":"1896_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02565-0","volume":"19","author":"D Singh","year":"2022","unstructured":"Singh D. Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer\u2019s disease. J Neuroinflammat. 2022;19:206.","journal-title":"J Neuroinflammat"},{"key":"1896_CR60","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00401-024-02828-5","volume":"148","author":"JM Phillips","year":"2024","unstructured":"Phillips JM, Winfree RL, Seto M, Schneider JA, Bennett DA, Dumitrescu LC, et al. Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer\u2019s disease. Acta Neuropathol. 2024;148:69.","journal-title":"Acta Neuropathol"},{"key":"1896_CR61","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s12035-014-9070-5","volume":"53","author":"Y Tang","year":"2016","unstructured":"Tang Y, Le W. Differential roles of M1 and M2 microglia in neurodegenerative diseases. Mol Neurobiol. 2016;53:1181\u201394.","journal-title":"Mol Neurobiol"},{"key":"1896_CR62","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10787-019-00613-5","volume":"28","author":"K Yao","year":"2020","unstructured":"Yao K, Zu HB. Microglial polarization: novel therapeutic mechanism against Alzheimer\u2019s disease. Inflammopharmacology. 2020;28:95\u2013110.","journal-title":"Inflammopharmacology"},{"key":"1896_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304687","volume":"11","author":"X Zhong","year":"2024","unstructured":"Zhong X, Gong S, Meng L, Yao W, Du K, Jiao L, et al. Cordycepin modulates microglial M2 polarization coupled with mitochondrial metabolic reprogramming by targeting HKII and PDK2. Adv Sci. 2024;11:e2304687.","journal-title":"Adv Sci"},{"key":"1896_CR64","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1007\/s11427-016-5083-9","volume":"59","author":"X Hu","year":"2016","unstructured":"Hu X, Wang T, Jin F. Alzheimer\u2019s disease and gut microbiota. Sci China Life Sci. 2016;59:1006\u201323.","journal-title":"Sci China Life Sci"},{"key":"1896_CR65","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1136\/gutjnl-2021-326269","volume":"71","author":"C Chen","year":"2022","unstructured":"Chen C, Liao J, Xia Y, Liu X, Jones R, Haran J, et al. Gut microbiota regulate Alzheimer\u2019s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation. Gut. 2022;71:2233\u201352.","journal-title":"Gut"},{"key":"1896_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122132","volume":"333","author":"L Bello-Corral","year":"2023","unstructured":"Bello-Corral L, Alves-Gomes L, Fern\u00e1ndez-Fern\u00e1ndez JA, Fern\u00e1ndez-Garc\u00eda D, Casado-Verdejo I, S\u00e1nchez-Valde\u00f3n L. Implications of gut and oral microbiota in neuroinflammatory responses in Alzheimer\u2019s disease. Life Sci. 2023;333:122132.","journal-title":"Life Sci"},{"key":"1896_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.879318","volume":"16","author":"Z Li","year":"2022","unstructured":"Li Z, Zhou J, Liang H, Ye L, Lan L, Lu F, et al. Differences in alpha diversity of gut microbiota in neurological diseases. Front Neurosci. 2022;16:879318.","journal-title":"Front Neurosci"},{"key":"1896_CR68","doi-asserted-by":"crossref","unstructured":"Jemimah S, Chabib CMM, Hadjileontiadis L, AlShehhi A. Gut microbiome dysbiosis in Alzheimer\u2019s disease and mild cognitive impairment: A systematic review and meta-analysis. PLoS One. 2023;18:e0285346.","DOI":"10.1371\/journal.pone.0285346"},{"key":"1896_CR69","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/5127157","volume":"2023","author":"Y Zang","year":"2023","unstructured":"Zang Y, Lai X, Li C, Ding D, Wang Y, Zhu Y. The role of gut microbiota in various neurological and psychiatric disorders-an evidence mapping based on quantified evidence. Mediators Inflamm. 2023;2023:5127157.","journal-title":"Mediators Inflamm"},{"key":"1896_CR70","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1111\/ene.15961","volume":"30","author":"G Chen","year":"2023","unstructured":"Chen G, Zhou X, Zhu Y, Shi W, Kong L. Gut microbiome characteristics in subjective cognitive decline, mild cognitive impairment and Alzheimer\u2019s disease: a systematic review and meta-analysis. Eur J Neurol. 2023;30:3568\u201380.","journal-title":"Eur J Neurol"},{"key":"1896_CR71","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5578958","volume":"2021","author":"Q Pan","year":"2021","unstructured":"Pan Q, Li YQ, Guo K, Xue M, Gan Y, Wang K, et al. Elderly patients with mild cognitive impairment exhibit altered gut microbiota profiles. J Immunol Res. 2021;2021:5578958.","journal-title":"J Immunol Res"},{"key":"1896_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-020-00906-0","volume":"18","author":"LA Draper","year":"2020","unstructured":"Draper LA, Ryan FJ, Dalmasso M, Casey PG, McCann A, Velayudhan V, et al. Autochthonous faecal viral transfer (FVT) impacts the murine microbiome after antibiotic perturbation. BMC Biol. 2020;18:173.","journal-title":"BMC Biol"},{"key":"1896_CR73","doi-asserted-by":"publisher","first-page":"477","DOI":"10.18632\/aging.203826","volume":"14","author":"CC Hung","year":"2022","unstructured":"Hung CC, Chang CC, Huang CW, Nouchi R, Cheng CH. Gut microbiota in patients with Alzheimer\u2019s disease spectrum: a systematic review and meta-analysis. Aging. 2022;14:477\u201396.","journal-title":"Aging"},{"key":"1896_CR74","doi-asserted-by":"publisher","first-page":"e1001923","DOI":"10.1371\/journal.pmed.1001923","volume":"12","author":"AH Havelaar","year":"2015","unstructured":"Havelaar AH, Kirk MD, Torgerson PR, Gibb HJ, Hald T, Lake RJ, et al. World health organization global estimates and regional comparisons of the burden of foodborne disease in 2010. PLoS Med. 2015;12:e1001923.","journal-title":"PLoS Med"},{"key":"1896_CR75","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00116-21","volume":"89","author":"SM Callahan","year":"2021","unstructured":"Callahan SM, Dolislager CG, Johnson JG. The host cellular immune response to infection by Campylobacter Spp. and its role in disease. Infect Immun. 2021;89:e0011621.","journal-title":"Infect Immun"},{"key":"1896_CR76","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.4014\/jmb.1803.03020","volume":"28","author":"JF Garcia-Mazcorro","year":"2018","unstructured":"Garcia-Mazcorro JF, Pedreschi R, Chew B, Dowd SE, Kawas JR, Noratto G. Dietary supplementation with Raspberry extracts modifies the fecal microbiota in obese diabetic db\/db mice. J Microbiol Biotechnol. 2018;28:1247\u201359.","journal-title":"J Microbiol Biotechnol"},{"key":"1896_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-19393-0","volume":"12","author":"A Kaiyrlykyzy","year":"2022","unstructured":"Kaiyrlykyzy A, Kozhakhmetov S, Babenko D, Zholdasbekova G, Alzhanova D, Olzhayev F, et al. Study of gut microbiota alterations in Alzheimer\u2019s dementia patients from Kazakhstan. Sci Rep. 2022;12:15115.","journal-title":"Sci Rep"},{"key":"1896_CR78","doi-asserted-by":"publisher","first-page":"18971","DOI":"10.1021\/acs.jafc.4c04193","volume":"72","author":"N Wang","year":"2024","unstructured":"Wang N, Dilixiati Y, Xiao L, Yang H, Zhang Z. Different short-chain fatty acids unequally modulate intestinal homeostasis and reverse obesity-related symptoms in lead-exposed high-fat diet mice. J Agric Food Chem. 2024;72:18971\u201385.","journal-title":"J Agric Food Chem"},{"key":"1896_CR79","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2152307","volume":"14","author":"P Paone","year":"2022","unstructured":"Paone P, Suriano F, Jian C, Korpela K, Delzenne NM, Van Hul M, et al. Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion. Gut Microbes. 2022;14:2152307.","journal-title":"Gut Microbes"},{"key":"1896_CR80","doi-asserted-by":"publisher","first-page":"24823","DOI":"10.1021\/acs.jafc.4c05577","volume":"72","author":"B Sun","year":"2024","unstructured":"Sun B, Wang Y, Bai J, Li X, Ma L, Man S. Litchi Procyanidins ameliorate DSS-induced colitis through gut microbiota-dependent regulation of Treg\/Th17 balance. J Agric Food Chem. 2024;72:24823\u201332.","journal-title":"J Agric Food Chem"},{"key":"1896_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1832857","volume":"12","author":"L Ma","year":"2020","unstructured":"Ma L, Ni Y, Wang Z, Tu W, Ni L, Zhuge F, et al. Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice. Gut Microbes. 2020;12:1\u201319.","journal-title":"Gut Microbes"},{"key":"1896_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1107071","volume":"13","author":"D Hui","year":"2022","unstructured":"Hui D, Liu L, Azami NLB, Song J, Huang Y, Xu W, et al. The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial. Front Endocrinol (Lausanne). 2022;13:1107071.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1896_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41283-w","volume":"14","author":"Y Xia","year":"2023","unstructured":"Xia Y, Xiao Y, Wang ZH, Liu X, Alam AM, Haran JP, et al. Bacteroides Fragilis in the gut microbiomes of Alzheimer\u2019s disease activates microglia and triggers pathogenesis in neuronal C\/EBP\u03b2 transgenic mice. Nat Commun. 2023;14:5471.","journal-title":"Nat Commun"},{"key":"1896_CR84","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000515700","volume":"77","author":"HJ Kincaid","year":"2021","unstructured":"Kincaid HJ, Nagpal R, Yadav H. Diet-microbiota-brain axis in Alzheimer\u2019s disease. Ann Nutr Metab. 2021;77:21\u20137.","journal-title":"Ann Nutr Metab"},{"key":"1896_CR85","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3389\/fneur.2018.00549","volume":"9","author":"JR Guedes","year":"2018","unstructured":"Guedes JR, Lao T, Cardoso AL, El Khoury J. Roles of microglial and monocyte chemokines and their receptors in regulating Alzheimer\u2019s disease-associated amyloid-\u03b2 and Tau pathologies. Front Neurol. 2018;9:549.","journal-title":"Front Neurol"},{"key":"1896_CR86","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.tibs.2019.04.004","volume":"44","author":"APIJ Guo","year":"2019","unstructured":"Guo APIJ. D. Drug-target association kinetics in drug discovery. Trends Biochem Sci. 2019;44:861\u201371.","journal-title":"Trends Biochem Sci"},{"key":"1896_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.bios.2025.117308","volume":"278","author":"T \u0160pringer","year":"2025","unstructured":"\u0160pringer T, Bockov\u00e1 M, Slab\u00fd J, Sohrabi F, \u010capkov\u00e1 M, Homola J. Surface plasmon resonance biosensors and their medical applications. Biosens Bioelectron. 2025;278:117308.","journal-title":"Biosens Bioelectron"},{"key":"1896_CR88","doi-asserted-by":"publisher","first-page":"81","DOI":"10.18097\/PBMCR1536","volume":"71","author":"ZM Shaihutdinova","year":"2025","unstructured":"Shaihutdinova ZM, Pashirova TN, Masson P. Slow-binding inhibitors of enzymes: kinetic characteristics and pharmacological interest. Biomed Khim. 2025;71:81\u201394.","journal-title":"Biomed Khim"},{"key":"1896_CR89","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/03602532.2017.1306544","volume":"49","author":"K Wang","year":"2017","unstructured":"Wang K, Feng X, Chai L, Cao S, Qiu F. The metabolism of berberine and its contribution to the pharmacological effects. Drug Metab Rev. 2017;49:139\u201357.","journal-title":"Drug Metab Rev"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01896-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01896-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01896-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T11:02:47Z","timestamp":1787050967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01896-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":89,"alternative-id":["1896"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01896-5","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}